EDITORIALS

Prostate Biopsy: A Wealth of Information When Done and Interpreted Correctly

Peter R. Carroll

JCO Mar 13 2000: 1161–1163. [Full Text] [PDF]

GENITOURINARY CANCER
	Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer
	Anthony V. D’Amico, Richard Whittington, S. Bruce Malkowicz, Delray Schultz, Julia Fondurulia, Ming-Hui Chen, John E. Tomaszewski, Andrew A. Renshaw, Alan Wein, and Jerome P. Richie
	JCO Mar 13 2000: 1164–1172. [Abstract] [Full Text] [PDF]
	Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients
	Robert J. Motzer, Madhu Mazumdar, Joel Sheinfeld, Dean F. Bajorin, Homer A. Macapinlac, Manjit Bains, Lilian Reich, Carlos Flombaum, Tania Mariani, William P. Tong, and George J. Bosl
	JCO Mar 13 2000: 1173–1180. [Abstract] [Full Text] [PDF]
	Results of Treatment After Relapse From High-Dose Chemotherapy in Germ Cell Tumors
	Pierluigi Porcu, Sumeet Bhatia, Matt Sharma, and Lawrence H. Einhorn
	JCO Mar 13 2000: 1181–1186. [Abstract] [Full Text] [PDF]
	Examining the Role of Neoadjuvant Androgen Deprivation in Patients Undergoing Prostate Brachytherapy
	Louis Potters, Taryn Torre, Richard Ashley, and Steven Leibel
	JCO Mar 13 2000: 1187–1192. [Abstract] [Full Text] [PDF]

GYNECOLOGIC CANCER
	Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group
	Martine J. Piccart, John A. Green, Angel Jimenez Lacave, Nick Reed, Ignace Vergote, Pierluigi Benedetti-Panici, Andrea Bonetti, Vera Kristeller-Tome, Cesar Mendiola Fernandez, Desmond Curran, Martine Van Glabbeke, Denis Lacombe, Marie-Claire Pinel, and Serge Pecorelli
	JCO Mar 13 2000: 1193–1202. [Abstract] [Full Text] [PDF]

BREAST CANCER
	Factors That Predict the Referral of Breast Cancer Patients Onto Clinical Trials by Their Surgeons and Medical Oncologists
	Laura A. Siminoff, Amy Zhang, Natalie Colabianchi, Christina M. Saunders Sturm, and Quansheng Shen
	JCO Mar 13 2000: 1203–1211. [Abstract] [Full Text] [PDF]
	Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer
	Harold J. Burstein, Judith Manola, Jerry Younger, Leroy M. Parker, Craig A. Bunnell, Rochelle Scheib, Ursula A. Matulonis, Judy E. Garber, Kathryn D. Clarke, Lawrence N. Shulman, and Eric P. Winer
	JCO Mar 13 2000: 1212–1219. [Abstract] [Full Text] [PDF]
	Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis
	Timothy J. Whelan, Jim Julian, Jim Wright, Alejandro R. Jadad, and Mark L. Levine
	JCO Mar 13 2000: 1220–1229. [Abstract] [Full Text] [PDF]
	Building Bridges Between Physicians and Patients: Results of a Pilot Study Examining New Tools for Collaborative Decision Making in Breast Cancer
	Karen R. Sepucha, Jeffrey K. Belkora, Debasish Tripathy, and Laura J. Esserman
	JCO Mar 13 2000: 1230–1238. [Abstract] [Full Text] [PDF]

RADIATION ONCOLOGY
	Sucralfate in the Prevention of Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy: A North Central Cancer Treatment Group Phase III Double-Blind Placebo-Controlled Trial
	James A. Martenson, John W. Bollinger, Jeff A. Sloan, Paul J. Novotny, Rodolfo E. Urias, John C. Michalak, Thomas G. Shanahan, James A. Mailliard, and Ralph Levitt
	JCO Mar 13 2000: 1239–1245. [Abstract] [Full Text] [PDF]

BRAIN TUMORS
	Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study
	Alberto Broniscer, Cláudia da Costa Leite, Vera L. Lanchote, Telma M. S. Machado, and Lilian M. Cristófani
	JCO Mar 13 2000: 1246–1253. [Abstract] [Full Text] [PDF]
	Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme
	J. Del Rowe, C. Scott, M. Werner-Wasik, J. P. Bahary, W. J. Curran, R. C. Urtasun, and B. Fisher
	JCO Mar 13 2000: 1254–1259. [Abstract] [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children’s Cancer Group Study
	Mary Lou Schmidt, John N. Lukens, Robert C. Seeger, Garrett M. Brodeur, Hiroyuki Shimada, Robert B. Gerbing, Daniel O. Stram, Carlos Perez, Gerald M. Haase, and Katherine K. Matthay
	JCO Mar 13 2000: 1260–1268. [Abstract] [Full Text] [PDF]
	Prevention of Central Venous Catheter–Related Infections and Thrombotic Events in Immunocompromised Children by the Use of Vancomycin/Ciprofloxacin/Heparin Flush Solution: A Randomized, Multicenter, Double-Blind Trial
	Kelly J. Henrickson, Richard A. Axtell, Susan M. Hoover, Suzanne M. Kuhn, Jodi Pritchett, Sue C. Kehl, and John P. Klein
	JCO Mar 13 2000: 1269–1278. [Abstract] [Full Text] [PDF]
	Feasibility and Toxicity of Chemoembolization for Children With Liver Tumors
	Marcio H. Malogolowkin, Philip Stanley, David A. Steele, and Jorge A. Ortega
	JCO Mar 13 2000: 1279–1284. [Abstract] [Full Text] [PDF]
	Intensification With Intermediate-Dose Intravenous Methotrexate Is Effective Therapy for Children With Lower-Risk B-Precursor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study
	Donald H. Mahoney, Jr, Jonathan J. Shuster, Ruprecht Nitschke, Stephen Lauer, C. Philip Steuber, and Bruce Camitta
	JCO Mar 13 2000: 1285–1294. [Abstract] [Full Text] [PDF]

HEMATOLOGIC MALIGNANCIES
	CD56 Expression Is an Indicator of Poor Clinical Outcome in Patients With Acute Promyelocytic Leukemia Treated With Simultaneous All-Trans-Retinoic Acid and Chemotherapy
	Felicetto Ferrara, Fortunato Morabito, Bruno Martino, Giorgina Specchia, Vincenzo Liso, Francesco Nobile, Piernicola Boccuni, Rosa Di Noto, Fabrizio Pane, Mario Annunziata, Ettore Mariano Schiavone, Mariacarla De Simone, Cesare Guglielmi, Luigi Del Vecchio, and Francesco Lo Coco
	JCO Mar 13 2000: 1295–1300. [Abstract] [Full Text] [PDF]
	Risk Factors for Severe Neuropsychiatric Toxicity in Patients Receiving Interferon Alfa-2b and Low-Dose Cytarabine for Chronic Myelogenous Leukemia: Analysis of Cancer and Leukemia Group B 9013
	Martee L. Hensley, Bercedis Peterson, Richard T. Silver, Richard A. Larson, Charles A. Schiffer, and Ted P. Szatrowski
	JCO Mar 13 2000: 1301–1308. [Abstract] [Full Text] [PDF]
	Randomized Comparison of ACVBP and m-BACOD in the Treatment of Patients With Low-Risk Aggressive Lymphoma: The LNH87-1 Study
	Hervé Tilly, Nicolas Mounier, Pierre Lederlin, Josette Brière, Brigitte Dupriez, Catherine Sebban, André Bosly, Pierre Biron, Catherine Nouvel, Raoul Herbrecht, Dominique Bordessoule, and Bertrand Coiffier
	JCO Mar 13 2000: 1309–1315. [Abstract] [Full Text] [PDF]
	Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas
	Julie M. Vose, Richard L. Wahl, Mansoor Saleh, Ama Z. Rohatiner, Susan J. Knox, John A. Radford, Andrew D. Zelenetz, George F. Tidmarsh, Robert J. Stagg, and Mark S. Kaminski
	JCO Mar 13 2000: 1316–1323. [Abstract] [Full Text] [PDF]

HEAD AND NECK CANCER
	Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal Type
	Abderrahim Fandi, Mounir Bachouchi, Nacer Azli, Abdelkrim Taamma, Hammouda Boussen, Pierre Wibault, François Eschwege, Jean-Pierre Armand, Jonathan Simon, and Esteban Cvitkovic
	JCO Mar 13 2000: 1324–1330. [Abstract] [Full Text] [PDF]

GASTROINTESTINAL CANCER
	Value of Peptide Receptor Scintigraphy Using 123I-Vasoactive Intestinal Peptide and 111In-DTPA-D-Phe1-Octreotide in 194 Carcinoid Patients: Vienna University Experience, 1993 to 1998
	Markus Raderer, Amir Kurtaran, Maria Leimer, Peter Angelberger, Bruno Niederle, Heinrich Vierhapper, Friedrich Vorbeck, Michael H. L. Hejna, Werner Scheithauer, Johann Pidlich, and Irene Virgolini
	JCO Mar 13 2000: 1331–1336. [Abstract] [Full Text] [PDF]
	Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study
	Eric Van Cutsem, Michael Findlay, Bruno Osterwalder, Walter Kocha, David Dalley, Richard Pazdur, Jim Cassidy, Luc Dirix, Chris Twelves, David Allman, Jean-Francois Seitz, Jürgen Schölmerich, Hans Ulrich Burger, and Jaap Verweij
	JCO Mar 13 2000: 1337–1345. [Abstract] [Full Text] [PDF]

LUNG CANCER
	Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer
	Vincent A. Miller, Lee M. Krug, Kenneth K. Ng, Barbara Pizzo, Wendy Perez, Robert T. Heelan, and Mark G. Kris
	JCO Mar 13 2000: 1346–1350. [Abstract] [Full Text] [PDF]
	Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group
	Joachim von Pawel, Reinhard von Roemeling, Ulrich Gatzemeier, Michael Boyer, Lars Ove Elisson, Peter Clark, Denis Talbot, Augustin Rey, Thomas W. Butler, Vera Hirsh, Ian Olver, Bengt Bergman, Joseph Ayoub, Gary Richardson, David Dunlop, Anthony Arcenas, Robert Vescio, Jean Viallet, and Joseph Treat
	JCO Mar 13 2000: 1351–1359. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy
	Salvatore Siena, Roberta Schiavo, Paolo Pedrazzoli, and Carmelo Carlo-Stella
	JCO Mar 13 2000: 1360–1377. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES
	American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
	Bruce E. Hillner, James N. Ingle, James R. Berenson, Nora A. Janjan, Kathy S. Albain, Allan Lipton, Gary Yee, J. Sybil Biermann, Rowan T. Chlebowski, and David G. Pfister
	JCO Mar 13 2000: 1378–1391. [Abstract] [Full Text] [PDF]

ANNOUNCEMENTS

JCO Mar 13 2000: 1398. [Full Text] [PDF]

CORRESPONDENCE

Chemotherapy With and Without Anthracycline

Giorgio Cocconi and R. Fossati C. Confalonieri A. Tinazzi

JCO Mar 13 2000: 1392–1393. [Full Text] [PDF]

Docetaxel, Cisplatin, Fluorouracil, and Leucovorin in Locally Advanced Head and Neck Cancer

Jim Janinis, Gerassimos Panagos, and A. Dimitrios Colevas

JCO Mar 13 2000: 1393–1395. [Full Text] [PDF]

Expression of Ikaros Isoforms in Acute Lymphoblastic Leukemia Cell Lines

Fumihiko Ishimaru and Fatih M. Uckun

JCO Mar 13 2000: 1395–1397. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.